PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Budesonide - Oesophagitis (maintenance)

PAD Profile : Budesonide - Oesophagitis (maintenance)

Keywords :
eosinophilic oesophagitis, esophagitis, budesonide orodispersible, EOS, EoE
Brand Names Include :
Jorveza

Traffic Light Status

Status 1 of 1.

Status :
Blue
Formulations :
  • Oro-dispersible
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
03 November 2021
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the use of budesonide for maintenance of Eosinophilic Oesophagitis at the lowest effective dose.

Prescribing will be initiated by the specialist and continue for an initial 3 months before a request is made to the primary care clinician.
A BLUE information sheet for prescribers can be found below.
 

Associated BNF Codes

01. Gastro-Intestinal System
01.05.02. Corticosteroids
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More